The groundbreaking therapy of this peptide represents a major advance in the management of the condition. Unlike existing therapies, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide466584.review-blogger.com/63709425/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment